Toxicological aspects of injectable gold-hyaluronan combination as a treatment for neuroinflammation

Histology and Histopathology

Volumn 29, Issue 4, 2014, Pages 447-456

  Pedersen, Dan Sonne ^a   Locht, Linda J ^a   Tran, Thao P ^a   Markholt, Sara ^a   Rungby, Jørgen ^a   Larsen, Agnete ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Autometallography; Dissolucytosis; Hyaluronic acid; Metallic gold; Neuroinflammation

Indexed keywords

ANTIINFLAMMATORY AGENT; GOLD DERIVATIVE; HYALURONIC ACID;

ANIMAL; BAGG ALBINO MOUSE; BRAIN; CELL LINE; DRUG EFFECTS; FEMALE; INFLAMMATION; METABOLISM; NERVE CELL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN; CELL LINE; FEMALE; GOLD COMPOUNDS; HYALURONIC ACID; INFLAMMATION; MICE, INBRED BALB C; NEURONS;

EID: 84897098875     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Aharoni R. and Arnon R. (2009). Linkage between immunomodulation, neuroprotection and neurogenesis, Drug News Perspect, 22, 301-312.
2. Amor S., Puentes F., Baker D. and van der Valk P. (2010). Inflammation in neurodegenerative diseases. Immunology 129, 154-169.
3. Bergen H.T., Monkman N. and Mobbs C.V. (1996). Injection with gold thioglucose impairs sensitivity to glucose: evidence that glucoseresponsive neurons are important for long-term regulation of body weight. Brain Res. 734, 332-336.
4. Burmester G.R. (2001). Molecular mechanisms of action of gold in treatment of rheumatoid arthritis--an update. Z Rheumatol, 60, 167-173 (in german).
5. Challet E., Bernard D.J. and Turek F.W. (1999). Gold-thioglucoseinduced hypothalamic lesions inhibit metabolic modulation of light-induced circadian phase shifts in mice. Brain Res, 824, 18-27.
6. Constantinescu C.S., Farooqi N., O'Brien K. and Gran B. (2011). Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br. J Pharmacol. 164, 1079-1106.
7. Danscher G. (2002). In vivo liberation of gold ions from gold implants. Autometallographic tracing of gold in cells adjacent to metallic gold. Histochem. Cell Biol. 117, 447-452.
8. Danscher G. and Stoltenberg M. (2006). Silver enhancement of quantum dots resulting from (1) metabolism of toxic metals in animals and humans, (2) in vivo, in vitro and immersion created zinc-sulphur/zinc-selenium nanocrystals, (3) metal ions liberated from metal implants and particles, Prog Histochem Cytochem, 41, 57-139.
9. Danscher G., Stoltenberg M. and Juhl S. (1994). How to detect gold, silver and mercury in human brain and other tissues by autometallographic silver amplification, Neuropathol. Appl. Neurobiol. 20, 454-467.
10. Das S. and Basu A. (2008). Inflammation: a new candidate in modulating adult neurogenesis. J. Neurosci. Res. 86, 1199-1208.
11. Debons A.F., Krimsky I., Maayan M.L., Fani K. and Jemenez F.A. (1977). Gold thioglucose obesity syndrome, Fed. Proc. 36, 143-147.
12. Debons A.F., Krimsky, I., From, A, Siclari E., Maayan M.L., Fni K. and Jiménez F.A. (1979). Action of gold thioglucose on pericapillary structures in the ventromedial hypothalamus. J. Pathol. 129, 73-81.
13. Ekdahl C.T. (2012). Microglial activation tuning and pruning adult neurogenesis. Front. Pharmacol. 3, 41.
14. Fam A.G., Gordon D.A., Sarkozi J., Blair G.R., Cooper P.W., Harth M. and Lewis A.J. (1984). Neurologic complications associated with gold therapy for rheumatoid arthritis, J. Rheumatol. 11, 700-706.
15. Forestier J. (1934). Rheumatoid arthritis and its treatment by gold salts. The Lancet, 224, 646-648.
16. Franklin K.B.J. and Paxinos G. (2007). The mouse brain in stereotaxic coordinates. Academic Press.
17. Giovannoni G. and Ebers G. (2007). Multiple sclerosis: the environment and causation. Curr. Opin. Neurol. 20, 261-68.
18. Graabaek P.M. and Pedersen S.M. (1988). Effect of two gold compounds on lysosomes. Ann. Rheum. Dis, 47, 509-514.
19. Jaeger G.T., Larsen S., Soli N. and Moe L. (2006). Double-blind, placebo-controlled trial of the pain-relieving effects of the implantation of gold beads into dogs with hip dysplasia. Vet. Rec. 158, 722-726.
20. Jaeger G.T., Larsen S., Soli N. and Moe L. (2007). Two years follow-up study of the pain-relieving effect of gold bead implantation in dogs with hip-joint arthritis, Acta Vet. Scand. 49, 9.
21. Kurz T., Terman A., Gustafsson B. and Brunk U.T. (2008). Lysosomes and oxidative stress in aging and apoptosis. Biochim. Biophys. Acta 1780, 1291-1303.
22. Larsen A., Stoltenberg M., Sondergaard C., Bruhn M. and Danscher G. (2005). In vivo distribution of bismuth in the mouse brain: influence of long-term survival and intracranial placement on the uptake and transport of bismuth in neuronal tissue, Basic Clin. Pharmacol. Toxicol. 97, 188-196.
23. Larsen A., Stoltenberg M. and Danscher G. (2007). In vitro liberation of charged gold atoms: autometallographic tracing of gold ions released by macrophages grown on metallic gold surfaces. Histochem. Cell Biol. 128, 1-6.
24. Larsen A., Kolind K., Pedersen D. S., Doering P., Pedersen M.O., Danscher G., Penkowa M. and Stoltenberg M. (2008). Gold ions bio-released from metallic gold particles reduce inflammation and apoptosis and increase the regenerative responses in focal brain injury. Histochem. Cell Biol. 130, 681-692.
25. Lassmann H. (2011). Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease. J. Neural Transm. 118, 747-752.
26. Locht L.J., Pedersen M.O., Markholt S., Bibby B.M., Larsen A., Penkowa M., Stoltenberg M. and Rungby J. (2010). Metallic silver fragments cause massive tissue loss in the mouse brain. Basic Clin. Pharmacol. Toxicol. 109, 1-10.
27. Lucas S.M., Rothwell N.J. and Gibson R.M. (2006). The role of inflammation in CNS injury and disease, Br J. Pharmacol. 147 (Suppl 1), S232-S240.
28. McFarland H.F. and Martin R. (2007). Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 8, 913-919.
29. Merchant B. (1998). Gold, the noble metal and the paradoxes of its toxicology. Biologicals 26, 49-59.
30. Mirshafiey A. and Mohsenzadegan M. (2008). Antioxidant therapy in multiple sclerosis. Immunopharmacol. Immunotoxicol. 31, 13-29.
31. Moller-Madsen B. and Thorlacius-Ussing O. (1984). Localization of gold in the anterior pituitary gland of rats exposed to sodium aurothiomalate. Exp. Mol. Pathol. 41, 74-80.
32. Moller-Madsen B., Mogensen S.C. and Danscher G. (1984). Ultrastructural localization of gold in macrophages and mast cells exposed to aurothioglucose. Exp. Mol. Pathol. 40, 148-154.
33. Pedersen M.O., Larsen A., Pedersen D.S., Stoltenberg, M. and Penkowa M. (2009a). Metallic gold treatment reduces proliferation of inflammatory cells, increases expression of VEGF and FGF, and stimulates cell proliferation in the subventricular zone following experimental traumatic brain injury. Histol Histopathol. 24, 573-586.
34. Pedersen M.O., Larsen A., Pedersen D.S., Stoltenberg M. and Penkowa M. (2009b). Metallic gold reduces TNFalpha expression, oxidative DNA damage and pro-apoptotic signals after experimental brain injury. Brain Res. 1271, 103-113.
35. Pedersen D.S., Fredericia P.M., Pedersen M.O., Stoltenberg M., Penkowa M., Danscher G., Rungby J. and Larsen A. (2012). Metallic gold slows disease progression, reduces cell death and induces astrogliosis while simultaneously increasing stem cell responses in an EAE rat model of multiple sclerosis. Histochem. Cell Biol. 138, 787-802.
36. Pedersen D.S., Tran T.P., Smidt K., Bibby B.M., Rungby J. and Larsen A. (2013). Metallic gold beads in hyaluronic acid: a novel form of gold-based immunosuppression? Investigations of the immunosuppressive effects of metallic gold on cultured J774 macrophages and on neuronal gene expression in experimental autoimmune encephalomyelitis. Biometals. 26, 369-385.
37. Persellin R.H. and Ziff M. (1966). The effect of gold salt on lysosomal enzymes of the peritoneal macrophage. Arthritis Rheum. 9, 57-65.
38. Rodrigues L.E. and Galle P. (1985). Lysosomotropism and anti-inflammatory action of gold salts. Rev. Rhum. Mal. Osteoartic. 52, 479-483 (in portugese).
39. Rungby J. (1990). An experimental study on silver in the nervous system and on aspects of its general cellular toxicity. Dan Med. Bull. 37, 442-449.
40. Sadauskas E., Jacobsen N.R., Danscher G., Stoltenberg M., Vogel U., Larsen A., Kreyling W. and Wallin H. (2009). Biodistribution of gold nanoparticles in mouse lung following intratracheal instillation. Chem. Cent. J. 3 16.
41. Schionning J.D. and Danscher G. (1999). Autometallographic mercury correlates with degenerative changes in dorsal root ganglia of rats intoxicated with organic mercury, APMIS, 107, 303-10.
42. Schionning J.D., Poulsen E.H., Moller-Madsen B. and Danscher G. (1992). Autometallographic detection of gold in dorsal root ganglia of rats treated with sodium aurothiomalate. Exp. Mol. Pathol. 56, 239-247.
43. Schionning J.D., Danscher G., Christensen M.M., Ernst E. and Moller-Madsen B. (1993). Differentiation of silver-enhanced mercury and gold in tissue sections of rat dorsal root ganglia, Histochem J. 25, 107-111.
44. Sorensen F.W., Larsen J.O., Eide R. and Schionning J.D. (2000). Neuron loss in cerebellar cortex of rats exposed to mercury vapor: a stereological study, Acta Neuropathol. 100, 95-100.
45. Stoltenberg M., Larsen A., Zhao M., Danscher G. and Brunk U.T. (2002). Bismuth-induced lysosomal rupture in J774 cells. APMIS 110, 396-402.
46. Stoltenberg M., Schionning J.D., West M.J. and Danscher, G. (2003). Bismuth-induced neuronal cell death in rat dorsal root ganglion: a stereological study. Acta Neuropathol. 105, 351-357.
47. Terman A., Kurz T., Navratil M., Arriaga E.A. and Brunk U.T. (2010). Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid. Redox Signal. 12, 503-535.
48. Weiss J.J., Thompson G.R. and Lazaro R. (1982). Gold toxicity presenting as peripheral neuropathy. Clin. Rheumatol. 1, 285-289.
49. Wilkie D.A. and Gemensky-Metzler A.J. (2004). Agents for intraocular surgery. Vet. Clin. North. Am. Small Anim. Pract. 34, 801-823.
50. Yanni G., Nabil M., Farahat M.R., Poston R.N. and Panayi G.S. (1994). Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane, Ann. Rheum. Dis. 53, 315-322.
51. Zecca L., Wilms H., Geick S., Claasen J.H., Brandenburg L.O., Holzknecht C., Panizza M.L., Zucca F.A., Deuschl G., Sievers J. and Lucius R. (2008). Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease. Acta Neuropathol. 116, 47-55.